
Job Overview
Location
2 Locations
Job Type
Full-time
Category
Data & Analytics
Date Posted
April 4, 2026
Full Job Description
📋 Description
- • The Business Analytics Senior Analyst role is critical to driving the success of the 340B program across Covered Entities, pharmacies, and gateway initiatives by delivering data-driven insights that maximize program performance and support strategic business decisions.
- • Day-to-day responsibilities include developing relationships with internal and external stakeholders, conducting routine and ad hoc analyses, resolving data issues, managing reporting efforts such as manufacturer impact and direct replenishment reports, and utilizing internal databases to support data requests and file remediations.
- • The role is part of Evernorth Health Services, a division of The Cigna Group, which focuses on innovating pharmacy, care, and benefit solutions to improve health outcomes and increase accessibility for millions of people.
- • The analyst will deepen expertise in V340B platform tools including VHUB, Verisave, NDC Optimizer, and Referral Capture, while building skills in data analysis, stakeholder communication, and problem-solving to drive measurable improvements in program value and operational efficiency.
Skills & Technologies
About The Cigna Group
The Cigna Group is a global health services company formed in 1982 through the merger of Connecticut General and INA Corporation. It provides medical, dental, disability, life and accident insurance, pharmacy benefit management, and behavioral health services to employers, individuals and government entities. Headquartered in Bloomfield, Connecticut, the company operates in over 30 countries and jurisdictions, serving more than 180 million customer relationships worldwide through its subsidiaries and affiliates.
Subscribe to the weekly newsletter for similar remote roles and curated hiring updates.
Newsletter
Weekly remote jobs and featured talent.
No spam. Only curated remote roles and product updates. You can unsubscribe anytime.

